Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial keratoplasty outcomes of domestic versus imported donor corneas.

Indian journal of ophthalmology·2026
Same author

Safety and efficacy of various topical anesthesia for intravitreal injection: a randomized controlled trial.

International ophthalmology·2026
Same author

Efficacy of Topical Nepafenac Versus Nepafenac With Perioperative Cyclopentolate for Pain Management After Photorefractive Keratectomy: A Comparative Clinical Evaluation.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2026
Same author

Reper intraocular lens with artificial iris: Presentation and outcomes in patients with significant iris defects and Aphakia.

Indian journal of ophthalmology·2025
Same author

Reply: Comment on "Limited performance of ChatGPT-4v and ChatGPT-4o in image-based core radiology cases".

Clinical imaging·2025
Same author

Detection of subclinical corneal edema in fuchs' dystrophy using galilei tomography.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2025

Related Experiment Video

Updated: Apr 19, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

2.1K

[Micro-invasive glaucoma surgery].

Asaf Achiron, Nardeen Sharif, Romi Noy Achiron

    Harefuah
    |December 19, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Glaucoma treatment focuses on lowering intraocular pressure (IOP). Minimally invasive glaucoma surgery (MIGS) offers a new option to reduce IOP with fewer side effects, reviewing devices like iStent and Trabectome.

    More Related Videos

    Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
    06:35

    Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

    Published on: February 2, 2015

    18.0K
    Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
    06:46

    Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse

    Published on: July 25, 2025

    1.6K

    Related Experiment Videos

    Last Updated: Apr 19, 2026

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
    10:10

    Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

    Published on: February 15, 2022

    2.1K
    Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
    06:35

    Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

    Published on: February 2, 2015

    18.0K
    Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse
    06:46

    Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse

    Published on: July 25, 2025

    1.6K

    Area of Science:

    • Ophthalmology
    • Surgical Innovation
    • Glaucoma Management

    Context:

    • Intraocular pressure (IOP) reduction is the primary goal in glaucoma management.
    • Traditional treatments are supplemented by surgical interventions.
    • Minimally invasive glaucoma surgery (MIGS) has emerged as a significant advancement.

    Purpose:

    • To review the clinical experience with specific Minimally Invasive Glaucoma Surgery (MIGS) devices.
    • To evaluate the efficacy and safety of iStent, Bypass, Gold Micro Shunt, and Trabectome.
    • To provide insights into the current landscape of MIGS for glaucoma.

    Summary:

    • MIGS procedures aim to enhance trabecular meshwork outflow, thereby reducing IOP.
    • These techniques offer a favorable safety profile compared to traditional glaucoma surgeries.
    • Clinical data on iStent, Bypass, Gold Micro Shunt, and Trabectome are analyzed.

    Impact:

    • MIGS provides an alternative or adjunctive treatment for glaucoma patients.
    • These procedures can lead to significant IOP reduction with minimal side effects.
    • The review contributes to understanding the role of MIGS in modern glaucoma care.